Three-Year NHS Study Shows Blood Test Reduces Stage IV Cancer Diagnoses
The Galleri blood test demonstrated a four-fold increase in cancer detection rates and substantial reduction in stage IV cancer diagnoses in 142,000 participants.
Read More
Search Results for: liver disease
ClearNote Health Launches Enhanced Pancreatic Cancer Blood Test
ClearNote Health has launched an enhanced pancreatic cancer test, reporting 82.6% sensitivity and 97.5% specificity in high-risk patients using a multianalyte, multiomic blood-based approach.
Read More
Why Spatial Omics Is Transitioning From ‘Maps’ to ‘Mechanisms’
High-resolution maps showed us where cells live; the next phase of spatial omics is about extracting those cells and uncovering the molecular conversations that shape outcomes.
Read More
CDC Selects Cepheid as National Collaborator for Rapid Diagnostic Development
The CDC has named Cepheid one of four national collaborators to accelerate rapid diagnostic assay development for public health emergencies under a new federal initiative and IDIQ contract.
Read More
Illumina Secures CMS Reimbursement for TruSight Oncology Test
Illumina’s FDA-approved TruSight Oncology test will be reimbursed by CMS at $2,989.55 per test starting Jan. 1, 2026, enabling broader laboratory access to genomic profiling for Medicare beneficiaries.
Read More